Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Argenx Se ADR (ARGX)

Argenx Se ADR (ARGX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 21,072,912
  • Shares Outstanding, K 55,324
  • Annual Sales, $ 539,420 K
  • Annual Income, $ -408,270 K
  • 60-Month Beta 0.80
  • Price/Sales 77.47
  • Price/Cash Flow N/A
  • Price/Book 7.08
Trade ARGX with:

Options Overview Details

View History
  • Implied Volatility 30.89% ( -1.75%)
  • Historical Volatility 24.41%
  • IV Percentile 2%
  • IV Rank 7.43%
  • IV High 55.95% on 03/08/22
  • IV Low 28.88% on 01/12/23
  • Put/Call Vol Ratio 0.69
  • Today's Volume 692
  • Volume Avg (30-Day) 273
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 5,512
  • Open Int (30-Day) 5,892

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -3.10
  • Number of Estimates 14
  • High Estimate -1.91
  • Low Estimate -5.69
  • Prior Year -4.76
  • Growth Rate Est. (year over year) +34.87%

Price Performance

See More
Period Period Low Period High Performance
1-Month
364.63 +4.46%
on 12/28/22
404.90 -5.93%
on 01/13/23
+10.32 (+2.78%)
since 12/27/22
3-Month
351.51 +8.36%
on 11/11/22
407.93 -6.63%
on 12/01/22
+8.66 (+2.33%)
since 10/27/22
52-Week
249.50 +52.67%
on 01/28/22
407.93 -6.63%
on 12/01/22
+126.45 (+49.70%)
since 01/27/22

Most Recent Stories

More News
Immunocore Holdings PLC Sponsored ADR (IMCR) Soars 6.9%: Is Further Upside Left in the Stock?

Immunocore Holdings PLC Sponsored ADR (IMCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest...

IMCR : 60.69 (+0.03%)
ARGX : 380.90 (-0.31%)
Halozyme (HALO) Down 9.2% on Weak 2023 Financial Guidance

Though Halozyme (HALO) expects a year-over-year increase in revenues and earnings for 2023, the company's guidance fell short of Wall Street expectations.

RHHBY : 39.2900 (-0.23%)
JNJ : 168.23 (-0.39%)
HALO : 50.71 (-4.82%)
ARGX : 380.90 (-0.31%)
argenex SE (ARGX) Upgraded to Buy: What Does It Mean for the Stock?

argenex SE (ARGX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ARGX : 380.90 (-0.31%)
Halozyme (HALO) Stock Rises 35% in the Year so Far: Here's Why

Halozyme (HALO) is gaining on its proprietary drug delivery technology, ENHANZE. It expects strong revenues on the back of robust demand for its new partnered drugs.

RHHBY : 39.2900 (-0.23%)
JNJ : 168.23 (-0.39%)
HALO : 50.71 (-4.82%)
ARGX : 380.90 (-0.31%)
Why Earnings Season Could Be Great for argenx (ARGX)

argenx (ARGX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

ARGX : 380.90 (-0.31%)
4 Biotech Stocks Set to Outpace Q3 Earnings Estimates

Let us take a look at some biotech stocks, ARGX, BMRN, LLY and GMAB, which are poised to beat on third-quarter earnings.

BMRN : 117.27 (+0.25%)
LLY : 342.10 (-1.70%)
ARGX : 380.90 (-0.31%)
GMAB : 38.87 (+0.49%)
argenex SE (ARGX) Upgraded to Buy: Here's Why

argenex SE (ARGX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ARGX : 380.90 (-0.31%)
Is Argenx (ARGX) Outperforming Other Medical Stocks This Year?

Here is how argenex SE (ARGX) and McKesson (MCK) have performed compared to their sector so far this year.

ARGX : 380.90 (-0.31%)
MCK : 379.20 (-1.28%)
Are Medical Stocks Lagging Lantheus (LNTH) This Year?

Here is how Lantheus Holdings (LNTH) and argenex SE (ARGX) have performed compared to their sector so far this year.

LNTH : 56.20 (+0.64%)
ARGX : 380.90 (-0.31%)
Is Argenx (ARGX) Stock Outpacing Its Medical Peers This Year?

Here is how argenex SE (ARGX) and Immunocore Holdings PLC Sponsored ADR (IMCR) have performed compared to their sector so far this year.

ARGX : 380.90 (-0.31%)
IMCR : 60.69 (+0.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

argenx SE is a biopharmaceutical company. It focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer. The company's product pipeline consists of ARGX-113, ARGX-110 and ARGX-111 which are in clinical trials. argenx SE is based in Breda, the Netherlands.

See More

Key Turning Points

3rd Resistance Point 400.25
2nd Resistance Point 392.76
1st Resistance Point 386.83
Last Price 380.90
1st Support Level 373.41
2nd Support Level 365.92
3rd Support Level 359.99

See More

52-Week High 407.93
Last Price 380.90
Fibonacci 61.8% 347.41
Fibonacci 50% 328.71
Fibonacci 38.2% 310.02
52-Week Low 249.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar